{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:29:32Z","timestamp":1760189372159},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T00:00:00Z","timestamp":1394668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1007\/s12013-014-9860-4","type":"journal-article","created":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T13:33:13Z","timestamp":1394631193000},"page":"735-739","source":"Crossref","is-referenced-by-count":27,"title":["Etanercept in the Treatment of Intestinal Behcet\u2019s Disease"],"prefix":"10.1007","volume":"69","author":[{"given":"Dan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru-Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,13]]},"reference":[{"key":"9860_CR1","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2165\/00003495-200767140-00004","volume":"67","author":"A Gul","year":"2007","unstructured":"Gul, A. (2007). Standard and novel therapeutic approaches to Behcet\u2019s disease. Drugs, 67, 2013\u20132022.","journal-title":"Drugs"},{"key":"9860_CR2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s11605-006-0031-9","volume":"11","author":"SJ Chou","year":"2007","unstructured":"Chou, S. J., Chen, V. T., Jan, H. C., Lou, M. A., & Liu, Y. M. (2007). Intestinal perforations in Behcet\u2019s disease. Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract, 11, 508\u2013514.","journal-title":"Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract"},{"issue":"Suppl 2","key":"9860_CR3","doi-asserted-by":"crossref","first-page":"ii51","DOI":"10.1136\/ard.61.suppl_2.ii51","volume":"61","author":"PP Sfikakis","year":"2002","unstructured":"Sfikakis, P. P. (2002). Behcet\u2019s disease: A new target for anti-tumour necrosis factor treatment. Annals of the Rheumatic Diseases, 61(Suppl 2), ii51\u2013ii53.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"9860_CR4","first-page":"3","volume":"11","author":"K Papp","year":"2007","unstructured":"Papp, K., Keystone, E., & Shear, N. (2007). Mechanism of action, pharmacokinetic and drug interaction of etanercept. Dermatology, 11, 3\u201313.","journal-title":"Dermatology"},{"key":"9860_CR5","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/rheumatology\/kem034","volume":"46","author":"PP Sfikakis","year":"2007","unstructured":"Sfikakis, P. P., Markomichelakis, N., Alpsoy, E., Assaad-Khalil, S., Bodaghi, B., Gul, A., et al. (2007). Anti-TNF therapy in the management of Behcet\u2019s disease\u2014Review and basis for recommendations. Rheumatology, 46, 736\u2013741.","journal-title":"Rheumatology"},{"key":"9860_CR6","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/rheumatology\/kem101","volume":"46","author":"L Niccoli","year":"2007","unstructured":"Niccoli, L., Nannini, C., Benucci, M., Chindamo, D., Cassara, E., Salvarani, C., et al. (2007). Long-term efficacy of infliximab in refractory posterior uveitis of Behcet\u2019s disease: A 24-month follow-up study. Rheumatology, 46, 1161\u20131164.","journal-title":"Rheumatology"},{"key":"9860_CR7","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/01.rhu.0000249894.03016.de","volume":"12","author":"P Lin","year":"2006","unstructured":"Lin, P., & Liang, G. (2006). Behcet disease: Recommendation for clinical management of mucocutaneous lesions. Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases, 12, 282\u2013286.","journal-title":"Journal of Clinical Rheumatology: Practical Reports on Rheumatic & Musculoskeletal Diseases"},{"key":"9860_CR8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.semarthrit.2010.09.002","volume":"41","author":"A Arida","year":"2011","unstructured":"Arida, A., Fragiadaki, K., Giavri, E., & Sfikakis, P. P. (2011). Anti-TNF agents for Behcet\u2019s disease: Analysis of published data on 369 patients. Seminars in Arthritis and Rheumatism, 41, 61\u201370.","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"9860_CR9","first-page":"1078","volume":"335","author":"International Study Group for Behcet\u2019s Disease","year":"1990","unstructured":"International Study Group for Behcet\u2019s Disease. (1990). Criteria for diagnosis of Behcet\u2019s disease. Lancet, 335, 1078\u20131080.","journal-title":"Lancet"},{"key":"9860_CR10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.berh.2008.08.005","volume":"22","author":"S Yurdakul","year":"2008","unstructured":"Yurdakul, S., & Yazici, H. (2008). Behcet\u2019s syndrome. Best Practice & Research Clinical Rheumatology, 22, 793\u2013809.","journal-title":"Best Practice & Research Clinical Rheumatology"},{"key":"9860_CR11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.bor.0000197995.27579.9b","volume":"18","author":"N Pipitone","year":"2006","unstructured":"Pipitone, N., Olivieri, I., Cantini, F., Triolo, G., & Salvarani, C. (2006). New approaches in the treatment of Adamantiades\u2013Behcet\u2019s disease. Current Opinion in Rheumatology, 18, 3\u20139.","journal-title":"Current Opinion in Rheumatology"},{"key":"9860_CR12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1177\/0091270004273321","volume":"45","author":"H Zhou","year":"2005","unstructured":"Zhou, H. (2005). Clinical pharmacokinetics of etanercept: A fully humanized soluble recombinant tumor necrosis factor receptor fusion protein. Journal of Clinical Pharmacology, 45, 490\u2013497.","journal-title":"Journal of Clinical Pharmacology"},{"key":"9860_CR13","first-page":"1362","volume":"31","author":"S Ohno","year":"2004","unstructured":"Ohno, S., Nakamura, S., Hori, S., Shimakawa, M., Kawashima, H., Mochizuki, M., et al. (2004). Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet\u2019s disease with refractory uveoretinitis. The Journal of Rheumatology, 31, 1362\u20131368.","journal-title":"The Journal of Rheumatology"},{"key":"9860_CR14","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0009-9236(02)17635-1","volume":"73","author":"H Lee","year":"2003","unstructured":"Lee, H., Kimko, H. C., Rogge, M., Wang, D., Nestorov, I., & Peck, C. C. (2003). Population pharmacokinetic and pharmacodynamic modeling of etanercept using logistic regression analysis. Clinical Pharmacology and Therapeutics, 73, 348\u2013365.","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"9860_CR15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1345\/aph.19126","volume":"34","author":"JM Korth-Bradley","year":"2000","unstructured":"Korth-Bradley, J. M., Rubin, A. S., Hanna, R. K., Simcoe, D. K., & Lebsack, M. E. (2000). The pharmacokinetics of etanercept in healthy volunteers. The Annals of Pharmacotherapy, 34, 161\u2013164.","journal-title":"The Annals of Pharmacotherapy"},{"key":"9860_CR16","first-page":"98","volume":"32","author":"M Melikoglu","year":"2005","unstructured":"Melikoglu, M., Fresko, I., Mat, C., Ozyazgan, Y., Gogus, F., Yurdakul, S., et al. (2005). Short-term trial of etanercept in Behcet\u2019s disease: A double blind, placebo controlled study. The Journal of Rheumatology, 32, 98\u2013105.","journal-title":"The Journal of Rheumatology"},{"key":"9860_CR17","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s10067-008-0857-5","volume":"27","author":"V Curigliano","year":"2008","unstructured":"Curigliano, V., Giovinale, M., Fonnesu, C., Cerquaglia, C., Verrecchia, E., Turco, S., et al. (2008). Efficacy of etanercept in the treatment of a patient with Behcet\u2019s disease. Clinical Rheumatology, 27, 933\u2013936.","journal-title":"Clinical Rheumatology"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-9860-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12013-014-9860-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-014-9860-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:44:35Z","timestamp":1559425475000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12013-014-9860-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,13]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["9860"],"URL":"https:\/\/doi.org\/10.1007\/s12013-014-9860-4","relation":{},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,13]]}}}